Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance.

Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance.

Item
http://www.wikidata.org/entity/Q40995589
Does endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome?Serum endocan levels in women with restless legs syndromeImpact of metabolic syndrome and its components on heart rate variability during hemodialysis: a cross-sectional study.The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence.Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome.Effect of Central Sympathoinhibition With Moxonidine on Sympathetic Nervous Activity in Polycystic Ovary Syndrome-A Randomized Controlled TrialEvodiamine Attenuates P2X-Mediated Inflammatory Injury of Human Umbilical Vein Endothelial Cells Exposed to High Free Fatty Acids
P2860

Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance.

Item
http://www.wikidata.org/entity/Q40995589
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sympathetic activation and end ...... obesity or insulin resistance.
@en
type
label
Sympathetic activation and end ...... obesity or insulin resistance.
@en
prefLabel
Sympathetic activation and end ...... obesity or insulin resistance.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Sympathetic activation and end ...... obesity or insulin resistance.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921